Study of in vitro and in vivo effects of the piperidine nitroxide Tempol—a potential new therapeutic agent for gliomas
- 30 April 2003
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (6) , 829-837
- https://doi.org/10.1016/s0959-8049(02)00742-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Neoplasms of the Central Nervous SystemPublished by Elsevier ,2010
- Relationship between Expression of p21WAF1/CIP1 and Radio resistance in Human GliomasJapanese Journal of Cancer Research, 1999
- Functional Expression of Human p21WAF1/CIP1Gene in Rat Glioma Cells Suppresses Tumor Growthin Vivoand Induces RadiosensitivityBiochemical and Biophysical Research Communications, 1997
- 1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell lineJournal of Neuroscience Research, 1996
- Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21 WAF1/CIP1 Mediated by STAT1Science, 1996
- Opposing effects of nitroxide free radicals in Escherichia coli mutants deficient in DNA repairBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1996
- Protective effect of the nitroxide tempol against the cardiotoxicity of adriamycinFree Radical Biology & Medicine, 1996
- A p53-independent Pathway for Activation of WAF1/CIP1 Expression Following Oxidative StressJournal of Biological Chemistry, 1995
- Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumoursEuropean Journal Of Cancer, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990